Compare EVGN & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGN | BMRA |
|---|---|---|
| Founded | 1999 | 1971 |
| Country | Israel | United States |
| Employees | N/A | 50 |
| Industry | Agricultural Chemicals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 11.5M |
| IPO Year | 2013 | 1995 |
| Metric | EVGN | BMRA |
|---|---|---|
| Price | $0.50 | $2.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 98.4K | ★ 187.3K |
| Earning Date | 05-20-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,453,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $73.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $1.45 |
| 52 Week High | $1.50 | $3.21 |
| Indicator | EVGN | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 42.49 | 71.51 |
| Support Level | $0.45 | $2.28 |
| Resistance Level | $0.86 | $2.49 |
| Average True Range (ATR) | 0.03 | 0.17 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 37.74 | 97.92 |
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.